Guardion Health Sciences, Inc. financial data

Location
Houston, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2024 - 13 Aug 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1020% % 51%
Quick Ratio 96% % -10%
Debt-to-equity 53% % -14%
Return On Equity 77% %
Return On Assets 50% %
Operating Margin -36% % 80%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,284,156 shares 0.85%
Common Stock, Shares, Outstanding 1,284,156 shares 1.3%
Common Stock, Value, Issued $1,284 USD 1.3%
Weighted Average Number of Shares Outstanding, Basic 1,284,156 shares 1.3%
Weighted Average Number of Shares Outstanding, Diluted 1,297,638 shares 2.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $12,055,791 USD 39%
Research and Development Expense $91,118 USD -64%
Selling and Marketing Expense $1,468,349 USD -9.3%
General and Administrative Expense $7,255,292 USD -1.8%
Operating Income (Loss) $4,387,053 USD 73%
Nonoperating Income (Expense) $1,287,625 USD -178%
Net Income (Loss) Attributable to Parent $6,374,939 USD
Earnings Per Share, Basic 5 USD/shares
Earnings Per Share, Diluted 5 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $14,822,826 USD 77%
Accounts Receivable, after Allowance for Credit Loss, Current $12,734 USD -99%
Inventory, Net $77,797 USD -97%
Assets, Current $15,292,249 USD 14%
Property, Plant and Equipment, Net $6,654 USD -85%
Assets $15,298,903 USD 14%
Accounts Payable, Current $113,412 USD -88%
Accrued Liabilities, Current $796,590 USD 76%
Liabilities, Current $917,327 USD -54%
Liabilities $1,548,581 USD -75%
Retained Earnings (Accumulated Deficit) $87,988,681 USD 6.8%
Stockholders' Equity Attributable to Parent $13,750,322 USD 90%
Liabilities and Equity $15,298,903 USD 14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $754,611 USD 60%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 1,284,156 shares 1.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $754,611 USD 89%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Operating Lease, Payments $3,000 USD
Additional Paid in Capital $101,737,719 USD 0.13%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%